BIOMERIEUX (EPA:BIM) | WebDisclosure

Basculer en Français

10604	Companies
225013	Keywords
153734	Articles
119072	Press releases

Home
Companies
BIOMERIEUX

REGULATED PRESS RELEASE

published on 11/05/2025 at 07:01, 7 months 15 days ago

Oxford Nanopore et bioMérieux lancent AmPORE-TB, une solution de séquençage, à usage de recherche uniquement, pour identifier rapidement la tuberculose résistante aux antibiotiques
Oxford Nanopore et bioMérieux lancent AmPORE-TB, une solution de séquençage pour identifier la tuberculose résistante aux antibiotiques, recommandée par l'OMS

Séquençage OMS Antibiotiques Tuberculose AmPORE-TB
BRIEF

published on 11/04/2025 at 11:22, 7 months 16 days ago

Status of shares and voting rights at bioMérieux in October 2025

Share Capital Voting Rights Shares BioMérieux Financial Transparency
BRIEF

published on 11/04/2025 at 11:22, 7 months 16 days ago

État des actions et droits de vote chez bioMérieux en octobre 2025

Droits De Vote Capital Social BioMérieux Actions Transparence Financière
REGULATED PRESS RELEASE

published on 11/04/2025 at 11:17, 7 months 16 days ago

Octobre 2025 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Communiqué mensuel sur le nombre total de droits de vote et d'actions de la société bioMérieux. Informations conformes aux réglementations en vigueur

Droits De Vote BioMérieux Actions Informations Mensuelles RCS LYON
BRIEF

published on 11/04/2025 at 07:06, 7 months 16 days ago

BioMérieux : Performance financière stable au troisième trimestre 2025

Résultats Financiers BioMérieux Diagnostic In Vitro Croissance Organique SPOTFIRE®
BRIEF

published on 11/04/2025 at 07:06, 7 months 16 days ago

BioMérieux Reports Solid Third-Quarter 2025 Performance

Product Innovation Organic Sales Growth Financial Forecast 2025 BIOFIRE® And SPOTFIRE® China Market Impact
REGULATED PRESS RELEASE

published on 11/04/2025 at 07:01, 7 months 16 days ago

bioMérieux – Information financière du 3ème trimestre 2025
bioMérieux communique ses informations financières pour le 3ème trimestre 2025. Croissance organique de +7,3% atteignant 2 992M€. Objectifs 2025 confirmés malgré contexte, chiffre d'affaires par application et région détaillé

Chiffre D'affaires BioMérieux Croissance Organique Objectifs 2025 3ème Trimestre
REGULATED PRESS RELEASE

published on 11/04/2025 at 07:01, 7 months 16 days ago

bioMérieux – Third-Quarter 2025 Business Review
bioMérieux reports 7.3% organic sales growth in the first nine months of 2025, meeting annual guidance. Sales reach €2,992m driven by strategic plans. Full-year guidance updated

Financial Results BioMérieux Strategic Plan Organic Sales Growth Full-year Guidance
BRIEF

published on 10/02/2025 at 14:37, 8 months 18 days ago

BioMérieux : État des actions et des droits de vote en septembre 2025

Droits De Vote Capital Social BioMérieux Actions Septembre 2025
BRIEF

published on 10/02/2025 at 14:37, 8 months 18 days ago

BioMérieux: Status of shares and voting rights as of September 2025

Share Capital Voting Rights BioMérieux Actions September 2025

Accesswire

Published on 06/20/2026 at 01:00, 23 hours 43 minutes ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 20 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 23 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 23 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 21:25, 3 hours 18 minutes ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 18 hours 43 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 4 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 4 hours ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 5 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

Les Echos

Published on 06/19/2026 at 19:33, 1 day 5 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 5 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 5 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 5 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 1 day 5 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE